ASP Isotopes unit Noble Africa agrees to merge with ENDRA Life Sciences

• ASP Isotopes unit Noble Africa is set to merge with a subsidiary of ENDRA Life Sciences, leaving Noble Africa as the surviving entity.
• The combined company plans to operate as Noble Africa Inc. with a planned Nasdaq listing under ticker NOBA.
• Noble Africa secured commitments for a private placement expected to raise about USD 50 million in gross proceeds, including USD 20 million from ASP Isotopes.
• The private placement is expected to close immediately before the merger closes.
• The transaction is intended to position Renergen’s Virginia Gas Project as a publicly traded helium platform.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ENDRA Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-071804), on June 25, 2026, and is solely responsible for the information contained therein.